menu
    • menu

    Company profile for Transpire Bio

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a team of dedicated professionals with expertise in delivering medicines to the body through the inhaled route. The Leadership Team combined has over 100 years of experience in developing inhaled medicines and bringing these medicines to the U.S. and European markets. Our purpose at Transpire Bio is framed by two core elements: Access and Innovation. For common diseases where adequate therapies exist, we seek to expand...
    We are a team of dedicated professionals with expertise in delivering medicines to the body through the inhaled route. The Leadership Team combined has over 100 years of experience in developing inhaled medicines and bringing these medicines to the U.S. and European markets. Our purpose at Transpire Bio is framed by two core elements: Access and Innovation. For common diseases where adequate therapies exist, we seek to expand access to these complex inhaled medicines globally by developing and commercializing lower-cost generic alternatives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Transpire BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8201 Peters Road Plantation, FL33324
    Telephone
    Telephone
    +1.954.315.0224
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.transpirebio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioAsia

    Not Confirmed

    envelop Contact Supplier

    BioAsia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    U.S. FDA Accepts Transpire Bio's ANDA for Generic Trelegy Filing
    U.S. FDA Accepts Transpire Bio's ANDA for Generic Trelegy Filing

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226303/0/en/Transpire-Bio-s-ANDA-for-Generic-Trelegy-Ellipta-Accepted-for-Filing-by-the-U-S-FDA.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Transpire Bio To Present At J.P. Morgan Healthcare Conference
    Transpire Bio To Present At J.P. Morgan Healthcare Conference

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215215/0/en/Transpire-Bio-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Transpire Bio Initiates Human Dosing In Clinical Trial
    Transpire Bio Initiates Human Dosing In Clinical Trial

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213449/0/en/Transpire-Bio-Announces-Completion-of-First-Human-Dosing-in-Clinical-Trial-Using-its-Novel-Inhalation-Formulation.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Transpire Bio Receives FDA EIR After Pre-Approval Inspection
    Transpire Bio Receives FDA EIR After Pre-Approval Inspection

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202213/0/en/Transpire-Bio-Manufacturing-Facility-Receives-the-Establishment-Inspection-Report-Following-a-Pre-Approval-Inspection-by-the-U-S-FDA.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Transpire Bio Receives FDA Orphan Drug Designation For 2 Diseases
    Transpire Bio Receives FDA Orphan Drug Designation For 2 Diseases

    15 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/15/3166934/0/en/Transpire-Bio-Granted-Orphan-Drug-Designation-by-the-U-S-FDA-For-Two-Rare-Diseases.html

    GLOBENEWSWIRE
    15 Oct 2025
    Share Share
    Transpire Bio's Generic Breo Ellipta Anda Accepted By Us FDA
    Transpire Bio's Generic Breo Ellipta Anda Accepted By Us FDA

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3154541/0/en/Transpire-Bio-s-ANDA-for-Generic-Breo-Ellipta-Accepted-for-Filing-By-the-U-S-FDA.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search